8 Results for "

Dabrafenib

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "Dabrafenib" in MCE Product Catalog:

83
83 Cited Publications
Cat. No.: HY-14660
CAS No.: 1195765-45-7
Purity:  99.94%
Synonyms: GSK2118436A; GSK2118436
Target:  

Raf CDK

Research Areas:  

Cancer

Dabrafenib (GSK2118436A) is an ATP-competitive inhibitor of Raf with IC50s of 5 nM and 0.6 nM for C-Raf and B-Raf V600E, respectively .
loading...
    loading...
83
83 Cited Publications
Cat. No.: HY-14660A
CAS No.: 1195768-06-9
Purity:  99.95%
Synonyms: GSK2118436 Mesylate; GSK 2118436B
Target:  

Raf

Research Areas:  

Cancer

Dabrafenib Mesylate is a potent and selective Raf kinase inhibitor with IC50s of 0.6 and 5.0 nM for Raf V600E and c-Raf, respectively.
loading...
    loading...
Cat. No.: HY-137346
CAS No.: 2769753-69-5
Purity:  99.63%
Synonyms: (S,R,S)-AHPC-Me-PEG2-Dabrafenib
Research Areas:  

Cancer

DD-03-156 ((S,R,S)-AHPC-Me-PEG2-dabrafenib) is a VHL-based PROTAC degrader targeting CDK17 and LIMK2. DD-03-156 serves as an excellent lead-like starting point for the development of selective chemical probes targeting CDK17 degradation .
loading...
    loading...
Cat. No.: HY-14660S
CAS No.: 1423119-98-5
Synonyms: GSK2118436A-d9; GSK2118436-d9
Dabrafenib-d9 is the deuterium labeled Dabrafenib. Dabrafenib (GSK2118436A) is an ATP-competitive inhibitor of Raf with IC50s of 5 nM and 0.6 nM for C-Raf and B-RafV600E, respectively .
loading...
    loading...
Cat. No.: HY-175659
CAS No.: 1195873-54-1
Target:  

Endogenous Metabolite

Research Areas:  

Others

Dabrafenib carboxylic acid is the carboxyl metabolite of dabrafenib (HY-14660) .
loading...
    loading...
Cat. No.: HY-150639
CAS No.: 2923700-82-5
Target:  

Raf

Research Areas:  

Cancer

Everafenib is a potent and blood-brain barrier (BBB) penetrant BRAF inhibitor, also inhibits MAPK signaling. Everafenib has inhibitory activity against a panel of V600EBRAF melanoma cell lines with IC50 values of 2-10 nM, which is better than Dabrafenib (HY-14660) and Vemurafenib (HY-12057). Everafenib has efficacy in an intracranial mouse model of metastatic melanoma .
loading...
    loading...
Cat. No.: HY-14660AR
CAS No.: 1195768-06-9
Synonyms: GSK2118436 Mesylate (Standard); GSK 2118436B (Standard)
Target:  

Raf Reference Standards

Research Areas:  

Cancer

Dabrafenib (Mesylate) (Standard) is the analytical standard of Dabrafenib (Mesylate). This product is intended for research and analytical applications. Dabrafenib Mesylate is a potent and selective Raf kinase inhibitor with IC50s of 0.6 and 5.0 nM for RafV600E and c-Raf, respectively.
loading...
    loading...
Cat. No.: HY-14660R
CAS No.: 1195765-45-7
Synonyms: GSK2118436A (Standard); GSK2118436 (Standard)
Target:  

Reference Standards Raf

Research Areas:  

Cancer

Dabrafenib (Standard) is the analytical standard of Dabrafenib. This product is intended for research and analytical applications. Dabrafenib (GSK2118436A) is an ATP-competitive inhibitor of Raf with IC50s of 5 nM and 0.6 nM for C-Raf and B-Raf V600E, respectively .
loading...
    loading...